Colon Biopsy Screening with AI

Reducing the burden of colon screening

With around 97% of NHS pathology labs facing staff shortages1, there is a pressing need for AI-assistance to help reduce the burden of tasks such as colon biopsy screening.

Our AI-powered colon biopsy screening tool streamlines clinical workflows by removing normal slides that do not require further intervention from pathologists. For slides flagged as abnormal by our tool, we offer triaging and decision support to further optimise the screening process.

1Histopathology Workforce Census. Royal College of Pathologists

This tool is currently for research use only and is currently going through CE-IVDR regulation.

"A significant workload in pathology departments comprises colonoscopic biopsies, with a notable percentage featuring normal tissue morphology. Histofy's AI tool, designed to identify and exclude this subgroup from the pathologist's workload, has the potential to substantially decrease reporting times and optimise the utilisation of specialist pathologist reporting sessions."
Colon screening AI Kishore
Dr Kishore Gopalakrishnan
Consultant Pathologist, University Hospitals Coventry & Warwickshire

Improved efficiency
in reporting

Colon biopsy screening time saving
Filter out normal colon slides that do not require stringent examination

Enhanced patient
management

Colon biopsy screening triage
Triage abnormal colon slides into urgent and non-urgent categories

Trustworthy AI
solution

Colon biopsy screening interpretable
Transparent decision support tool to assist with the identification of disease

Transparent AI at its core

Our technology provides transparent predictions, fostering trust and facilitating the practical integration of AI. We directly integrate our AI into pathology image management systems to prevent the need to move away from existing workflows.

Validation across ten NHS sites

Histofy AI news NIHR

Histofy partners with NIHR-funded consortium to transform colon biopsy screening with AI

•
March 10, 2023
•
News

Histofy, a company specialising in AI for pathology, today announces £500K of funding to develop algorithms for endoscopic colon biopsy screening, helping …

Leading research

Colon biopsy screening gut

 

Read our proof-of-concept work on interpretable colon biopsy screening (Graham et al. Gut, 2023).

Read the paper

Want to find out more?

Contact us